Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-05 Sale |
2024-03-07 6:53 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
20,054 | $12.06 | $241,805 | 7,272,809 (Direct) |
View |
| 2024-02-22 Sale |
2024-02-23 7:22 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
8,000 | $14.89 | $119,160 | 2,332,031 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 5:37 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
20,054 | $12.32 | $247,125 | 7,292,863 (Direct) |
View |
| 2024-02-13 Sale |
2024-02-15 6:00 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
50,000 | $10.16 | $507,985 | 4,703,133 (Direct) |
View |
| 2024-02-07 Sale |
2024-02-09 5:34 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
48,272 | $9.2182 | $444,981 | 9,858,536 (Indirect Direct) |
View |
| 2024-02-06 Sale |
2024-02-08 6:54 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $9.3028 | $106,489 | 7,312,917 (Direct) |
View |
| 2024-01-25 Sale |
2024-01-29 6:52 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $10.35 | $82,762 | 1,666,680 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 6:13 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
20,054 | $10.58 | $212,083 | 7,324,364 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 6:39 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
18,000 | $10.93 | $196,740 | 796,610 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 6:37 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
50,000 | $10.35 | $517,508 | 4,299,416 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-11 6:51 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
29,000 | $13.66 | $396,214 | 3,170,666 (Indirect Direct) |
View |
| 2024-01-09 Sale |
2024-01-11 6:50 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
20,054 | $13.62 | $273,202 | 7,344,418 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 8:03 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
55,853 | $9.4994 | $530,567 | 9,916,808 (Indirect Direct) |
View |
| 2023-12-28 Sale |
2024-01-02 4:58 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $10.58 | $84,654 | 1,674,680 (Direct) |
View |
| 2023-12-26 Sale |
2023-12-28 5:48 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
20,054 | $10.63 | $213,144 | 7,364,472 (Direct) |
View |
| 2023-12-15 Sale |
2023-12-19 7:22 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
18,000 | $9.6 | $172,800 | 814,610 (Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 6:44 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
20,141 | $9 | $181,269 | 53,823 (Direct) |
View |
| 2023-12-12 Sale |
2023-12-14 6:53 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
50,000 | $7.4928 | $374,638 | 4,424,416 (Direct) |
View |
| 2023-12-12 Sale |
2023-12-14 6:51 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $7.3987 | $84,693 | 7,384,526 (Direct) |
View |
| 2023-12-06 Sale |
2023-12-08 5:22 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
59,829 | $7.4946 | $448,394 | 9,982,661 (Indirect Direct) |
View |
| 2023-11-28 Sale |
2023-11-30 5:41 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $6.7195 | $76,918 | 7,395,973 (Direct) |
View |
| 2023-11-16 Sale |
2023-11-17 5:53 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $6.7599 | $20,280 | 1,681,536 (Direct) |
View |
| 2023-11-15 Sale |
2023-11-17 5:52 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
18,000 | $6.51 | $117,180 | 832,610 (Direct) |
View |
| 2023-11-14 Sale |
2023-11-16 6:55 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $6.3197 | $56,151 | 7,407,420 (Direct) |
View |
| 2023-11-14 Sale |
2023-11-16 6:54 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
50,000 | $6.8186 | $340,929 | 4,549,416 (Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 6:14 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
62,177 | $5.1675 | $321,301 | 10,079,403 (Indirect Direct) |
View |
| 2023-10-31 Sale |
2023-11-02 7:02 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $5.2745 | $46,864 | 7,416,305 (Direct) |
View |
| 2023-10-26 Sale |
2023-10-30 6:26 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $5.6283 | $16,885 | 1,689,914 (Direct) |
View |
| 2023-10-17 Sale |
2023-10-19 5:34 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $6.5822 | $58,483 | 7,425,190 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-22 Exercise |
2024-02-23 7:22 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
8,000 | $1.06 | 2,332,031 (Direct) |
View |
| 2024-02-22 Exercise |
2024-02-23 7:22 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
8,000 | $0 | 2,332,031 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 7:59 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
7,172 | $12.43 | 1,179,179 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 7:58 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
5,379 | $12.43 | 639,982 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 7:57 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
11,148 | $12.43 | 1,104,919 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 6:00 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $0 | 4,703,133 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 6:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $2.22 | 4,703,133 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-13 7:03 pm |
N/A 2034-02-09 |
RECURSION PHARMACEUTICALS INC. | RXRX | Mauro David J Chief Medical Officer |
155,345 | $0 | 725,592 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 7:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Mauro David J Chief Medical Officer |
1,892 | $10.09 | 725,592 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-13 7:01 pm |
N/A 2034-02-09 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
531,229 | $0 | 3,755,498 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 7:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
2,512 | $10.09 | 3,755,498 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-13 7:00 pm |
N/A 2034-02-09 |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
681,530 | $0 | 2,345,410 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 7:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
2,800 | $10.09 | 2,345,410 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-13 6:55 pm |
N/A 2034-02-09 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,011,495 | $0 | 10,866,798 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 6:55 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
3,233 | $10.09 | 10,866,798 (Direct) |
View |
| 2024-02-07 Conversion |
2024-02-09 5:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 9,858,536 (Direct) |
View |
| 2024-02-07 Gift |
2024-02-09 5:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 9,858,536 (Direct) |
View |
| 2024-02-07 Exercise |
2024-02-09 5:34 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,858,536 (Direct) |
View |
| 2024-02-07 Exercise |
2024-02-09 5:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,858,536 (Direct) |
View |
| 2024-01-25 Exercise |
2024-01-29 6:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $1.06 | 1,666,680 (Direct) |
View |
| 2024-01-25 Exercise |
2024-01-29 6:52 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $0 | 1,666,680 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 6:39 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
18,000 | $0 | 796,610 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 6:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
18,000 | $2.22 | 796,610 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 6:37 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $0 | 4,299,416 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 6:37 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $2.22 | 4,299,416 (Direct) |
View |
| 2024-01-03 Conversion |
2024-01-05 8:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
35,000 | $0 | 9,916,808 (Direct) |
View |
| 2024-01-03 Gift |
2024-01-05 8:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 9,916,808 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-05 8:03 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,916,808 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-05 8:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,916,808 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 6:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
1,900 | $0 | 58,077 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 6:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
1,393 | $0 | 55,216 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 6:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,203 | $0 | 3,199,666 (Direct) |
View |
| 2023-12-28 Exercise |
2024-01-02 4:58 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $1.06 | 1,674,680 (Direct) |
View |
| 2023-12-28 Exercise |
2024-01-02 4:58 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $0 | 1,674,680 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 7:22 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
18,000 | $0 | 814,610 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 7:22 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
18,000 | $2.22 | 814,610 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-14 6:53 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $0 | 4,424,416 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-14 6:53 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $2.22 | 4,424,416 (Direct) |
View |
| 2023-12-06 Conversion |
2023-12-08 5:22 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 9,982,661 (Direct) |
View |
| 2023-12-06 Gift |
2023-12-08 5:22 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 9,982,661 (Direct) |
View |
| 2023-12-06 Exercise |
2023-12-08 5:22 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,982,661 (Direct) |
View |
| 2023-12-06 Exercise |
2023-12-08 5:22 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,982,661 (Direct) |
View |
| 2023-11-16 Exercise |
2023-11-17 5:53 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $1.06 | 1,681,536 (Direct) |
View |
| 2023-11-16 Exercise |
2023-11-17 5:53 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $0 | 1,681,536 (Direct) |
View |
| 2023-11-15 Tax Withholding |
2023-11-17 5:53 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
5,378 | $7.18 | 1,681,536 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 5:52 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
18,000 | $0 | 832,610 (Direct) |
View |
| 2023-11-15 Tax Withholding |
2023-11-17 5:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
3,603 | $7.18 | 832,610 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 5:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
18,000 | $2.22 | 832,610 (Direct) |
View |
| 2023-11-15 Conversion |
2023-11-17 5:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,052,490 (Direct) |
View |
| 2023-11-15 Gift |
2023-11-17 5:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,052,490 (Direct) |
View |
| 2023-11-15 Tax Withholding |
2023-11-17 5:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
16,913 | $7.18 | 10,052,490 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 6:54 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $0 | 4,549,416 (Direct) |
View |
| 2023-11-15 Tax Withholding |
2023-11-16 6:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
7,172 | $7.18 | 4,549,416 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 6:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $2.22 | 4,549,416 (Direct) |
View |
| 2023-11-01 Conversion |
2023-11-03 6:14 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,079,403 (Indirect) |
View |
| 2023-11-01 Exercise |
2023-11-03 6:14 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 10,079,403 (Direct) |
View |
| 2023-11-01 Exercise |
2023-11-03 6:14 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,079,403 (Direct) |
View |
| 2023-10-26 Exercise |
2023-10-30 6:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $1.06 | 1,689,914 (Direct) |
View |
| 2023-10-26 Exercise |
2023-10-30 6:26 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $0 | 1,689,914 (Direct) |
View |